EDGEWISE THERAPEUTICS ($EWTX) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of -$0.46 per share, beating estimates of -$0.50 by $0.04. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $EWTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EDGEWISE THERAPEUTICS Insider Trading Activity
EDGEWISE THERAPEUTICS insiders have traded $EWTX stock on the open market 13 times in the past 6 months. Of those trades, 1 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $EWTX stock by insiders over the last 6 months:
- JOANNE M. DONOVAN (CMO) has made 0 purchases and 6 sales selling 121,588 shares for an estimated $4,210,201.
- BADREDDIN EDRIS has made 0 purchases and 5 sales selling 115,471 shares for an estimated $3,399,466.
- ALAN J RUSSELL (Chief Scientific Officer) sold 100,000 shares for an estimated $2,112,450
- JONATHAN C FOX purchased 10,700 shares for an estimated $199,403
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
EDGEWISE THERAPEUTICS Hedge Fund Activity
We have seen 111 institutional investors add shares of EDGEWISE THERAPEUTICS stock to their portfolio, and 74 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 2,041,203 shares (+234.7%) to their portfolio in Q4 2025, for an estimated $50,652,452
- DRIEHAUS CAPITAL MANAGEMENT LLC added 1,962,908 shares (+88.1%) to their portfolio in Q4 2025, for an estimated $48,709,562
- BELLEVUE GROUP AG removed 1,247,479 shares (-44.9%) from their portfolio in Q4 2025, for an estimated $30,956,191
- BANK OF AMERICA CORP /DE/ added 1,153,665 shares (+359.2%) to their portfolio in Q4 2025, for an estimated $28,628,196
- ALLIANCEBERNSTEIN L.P. added 958,910 shares (+1241.1%) to their portfolio in Q4 2025, for an estimated $23,795,351
- SOLEUS CAPITAL MANAGEMENT, L.P. added 910,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $22,581,650
- UBS GROUP AG removed 805,948 shares (-38.1%) from their portfolio in Q1 2026, for an estimated $25,387,362
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
EDGEWISE THERAPEUTICS Analyst Ratings
Wall Street analysts have issued reports on $EWTX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 11/14/2025
To track analyst ratings and price targets for EDGEWISE THERAPEUTICS, check out Quiver Quantitative's $EWTX forecast page.
EDGEWISE THERAPEUTICS Price Targets
Multiple analysts have issued price targets for $EWTX recently. We have seen 3 analysts offer price targets for $EWTX in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Laura Chico from Wedbush set a target price of $32.0 on 03/17/2026
- Tessa Romero from JP Morgan set a target price of $45.0 on 03/17/2026
- Cory Kasimov from Evercore ISI Group set a target price of $45.0 on 02/27/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
